Historia de los antibióticos

Barra lateral del artículo

PDF
Publicado: 10-12-2009
DOI: https://doi.org/10.51987/Rev.Hosp.Ital.B.Aires.v29i2.1048

Contenido principal del artículo

Waldo H. Belloso
Sección Farmacología Clínica. Hospital Italiano de Buenos Aires, Argentina

Resumen

.

Downloads

Download data is not yet available.

Detalles del artículo

Número

Vol. 29 Núm. 2 (2009): Revista del Hospital Italiano de Buenos Aires

Sección

Reseña Histórica
Creative Commons License

Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-CompartirIgual 4.0.

Cómo citar

1.
Belloso WH. Historia de los antibióticos. Rev Hosp Ital B.Aires [Internet]. 2009 Dec. 10 [cited 2026 Apr. 27];29(2):102-11. Available from: https://ojs.hospitalitaliano.org.ar/index.php/revistahi/article/view/1048

Referencias

huxtable RJ. a brief history of pharmacology, therapeutics and scientific thought. Proc West Pharmacol soc. 1999;42:181-223.

hunting P. the worshipful society of apothecaries of London. Postgrad Med J. 2004;80(939):41-4 DOI: https://doi.org/10.1136/pmj.2003.015933

Bordenave G. Louis Pasteur (1822-1895). Microbes infect. 2003;5(6):553-60. DOI: https://doi.org/10.1016/S1286-4579(03)00075-3

hayward Ja. historia de la medicina. Buenos aires: Fondo de cultura económica; 1989

Dubós R Pasteur. Barcelona: salvat; 1985.

schwartz M. the life and works of Louis Pasteur. J appl Microbiol. 2001;91(4):597-601. DOI: https://doi.org/10.1046/j.1365-2672.2001.01495.x

Zetterström R. Robert Koch (1843-1910): investigations and discoveries in relation to tuberculosis. acta Paediatr. 2006;95(5):514-6 DOI: https://doi.org/10.1080/08035250600707395

Waksman sa . Definition of antibiotics. antibiotic Med clin ther. 1956;2(2):82-6

Levy s. the antibiotic paradox. how miracle drugs are destroying the miracle. New York: Premium; 1992. DOI: https://doi.org/10.1007/978-1-4899-6042-9

schwartz Rs. Paul ehrlich’s magic bullets. N engl J Med. 2004;350(11):1079-80. DOI: https://doi.org/10.1056/NEJMp048021

Gensini GF, conti aa , Lippi D. the contributions of Paul ehrlich to infectious disease. J infect. 2007;54(3):221-4. DOI: https://doi.org/10.1016/j.jinf.2004.05.022

Bentley R. the development of penicillin: genesis of a famous antibiotic. Perspect Biol Med. 2005;48(3):444-52. DOI: https://doi.org/10.1353/pbm.2005.0068

Wennergren G, Lagercrantz h. “One sometimes finds what one is not looking for” (sir alexander Fleming): the most important medical discovery of the 20th century. acta Paediatr. 2007;96(1):141-4. DOI: https://doi.org/10.1111/j.1651-2227.2007.00098.x

Flemming a. the discovery of penicillin. Br Med Bull. 1944;2(1):4-5 DOI: https://doi.org/10.1093/oxfordjournals.bmb.a071032

Fielding J. history of penicillin. Lancet. 1980;1(8158):43-4. DOI: https://doi.org/10.1016/S0140-6736(80)90580-2

sykes R. Penicillin: from discovery to product. Bull World health Organ. 2001;79(8):778-9

edwards Di. history of antimicrobial chemotherapy. en: edwards Di, editor. antimicrobial drug action. London: Macmillan; 1980. p. 3-7. DOI: https://doi.org/10.1007/978-1-349-16360-1_1

Waksman sa . selman abraham Waksman, Ph.D. 22 July 1888-16 august 1973. Who “discovered” streptomycin? ann intern Med. 1973;79(5):646.

Zetterström R. selman a. Waksman (1888-1973) Nobel Prize in 1952 for the discovery of streptomycin, the first antibiotic effective against tuberculosis. acta Paediatr. 2007;96(2):317-9. DOI: https://doi.org/10.1111/j.1651-2227.2007.00182.x

Rolinson GN. Forty years of beta-lactam research. J antimicrob chemother. 1998;41(6):589-603. DOI: https://doi.org/10.1093/jac/41.6.589

Norris s, Mandell GL. the quinolones: history and overview. en: andriole Vt, editor. the quinolones. san Diego: academic Press; 1988. p.1-22. DOI: https://doi.org/10.1016/B978-0-12-059515-0.50005-6

Powers Jh. antimicrobial drug development-the past, the present, and the future. clin Microbiol infect. 2004;10 suppl 4:23-31. DOI: https://doi.org/10.1111/j.1465-0691.2004.1007.x

Ligon BL. sir howard Walter Florey--the force behind the development of penicillin. semin Pediatr infect Dis. 2004;15(2):109-14. DOI: https://doi.org/10.1053/j.spid.2004.04.001

Jevons MP. celbenin-resistant staphylococci. Br Med J. 1961;1(5219):124-5 DOI: https://doi.org/10.1136/bmj.1.5219.124-a

crisóstomo Mi, Westh h, tomasz a, et al. the evolution of methicillin resistance in staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones. Proc Natl acad sci U s a. 2001;98(17):9865-70. DOI: https://doi.org/10.1073/pnas.161272898

Bush K. antibacterial drug discovery in the 21st century. clin Microbiol infect. 2004;10 suppl 4:10-7. DOI: https://doi.org/10.1111/j.1465-0691.2004.1005.x

emmer cJ. Rapid diagnostic testing for URis in children: impact on physician decision making and costs. infect Med. 2002;19:160.

Gould iM. antibiotic policies and control of resistance. curr Opin infect Dis. 2002;15(4):395-400. DOI: https://doi.org/10.1097/00001432-200208000-00007

Levy sB. the challenge of antibiotic resistance. sci am. 1998;278(3):46-53. DOI: https://doi.org/10.1038/scientificamerican0398-46

cohen R. approaches to reduce antibiotic resistance in the community. Pediatr infect Dis J. 2006;25(10):977-80. DOI: https://doi.org/10.1097/01.inf.0000239271.10784.1e

Niederman Ms. Principles of appropriate antibiotic use. int J antimicrob agents. 2005;26 suppl 3:s170-5. DOI: https://doi.org/10.1016/S0924-8579(05)80324-3

Doern GV. Optimizing the management of community-acquired respiratory tract infections in the age of antimicrobial resistance. expert Rev anti infect ther. 2006;4(5):821-35. DOI: https://doi.org/10.1586/14787210.4.5.821

Phillips i. Withdrawal of growth-promoting antibiotics in europe and its effects in relation to human health. int J antimicrob agents. 2007;30(2):101-7. DOI: https://doi.org/10.1016/j.ijantimicag.2007.02.018

smith DL, Dushoff J, Morris JG. agricultural antibiotics and human health. PLos Med. 2005;2(8):e232. DOI: https://doi.org/10.1371/journal.pmed.0020232

smith DL, Johnson Ja, harris aD, et al. assessing risks for a pre-emergent pathogen: virginiamycin use and the emergence of streptogramin resistance in Enterococcus faecium. Lancet infect Dis. 2003;3(4):241-9. DOI: https://doi.org/10.1016/S1473-3099(03)00581-4

Kim Jh, Gallis ha . Observations on spiraling empiricism: its causes, allure, and perils, with particular reference to antibiotic therapy. am J Med. 1989;87(2):201-6. DOI: https://doi.org/10.1016/S0002-9343(89)80697-7

Lipsitch M, samore Mh. antimicrobial use and antimicrobial resistance: a population perspective. emerg infect Dis. 2002;8(4):347-54. errata en: emerg infect Dis 2002;8(5):540. DOI: https://doi.org/10.3201/eid0804.010312

Donskey cJ, chowdhry tK, hecker Mt, et al. effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N engl J Med. 2000;343(26):1925-32. DOI: https://doi.org/10.1056/NEJM200012283432604

Nord ce . studies on the ecological impact of antibiotics. eur J clin Microbiol infect Dis. 1990;9(7):517-8 DOI: https://doi.org/10.1007/BF01964294